UTHR
United Therapeutics Corporation · Healthcare
EVP and General Counsel Paul A Mahon sold $1.4M of United Therapeutics Corporation
Sold$1,396,755
$232.79Price
6,000Shares
−14%Stake
What UTHR did after the filing
- The stock from Mon, Apr 10 open, $225.62
- −3.1%
- S&P 500, same days
- +3.0%
Measured over 30 trading days, to the May 22 close.
Traded Thu, Apr 6. Filed Fri, Apr 7, 4:30 PM ET, after the close. Returns use the Apr 10 open and the May 22 close. Not investment advice.